Related Experiment Videos
Phenotypic and functional abnormalities of T lymphocytes in pathological hyperprolactinemia
R Gerli1, C Riccardi, I Nicoletti
1Istituto di Clinica Medica 1, University of Perugia, Italy.
Journal of Clinical Immunology
|November 1, 1987
Summary
Pathological hyperprolactinemia alters T cells, increasing immature CD1+ and CD4+ TQ1+ cells. Bromocriptine treatment normalized these T-cell abnormalities, confirming a neuroendocrine-immune system link.
Area of Science:
- Immunology
- Neuroendocrinology
- Cell Biology
Background:
- Pathological hyperprolactinemia is associated with hormonal imbalances.
- The interplay between the neuroendocrine and immune systems is complex.
- T-cell function can be influenced by hormonal milieu.
Purpose of the Study:
- To analyze T-cell phenotype and function in hyperprolactinemia patients.
- To compare T-cell profiles with healthy controls.
- To investigate the effect of bromocriptine on T-cell abnormalities.
Main Methods:
- Two-color immunofluorescence for T-cell phenotyping.
- Analysis of peripheral blood T cells.
- In vitro pokeweed mitogen-driven B-cell transformation assay.
Main Results:
- Increased CD4+ TQ1+ and immature CD1+ T cells in hyperprolactinemic patients.
- T-cell abnormalities resolved after bromocriptine treatment.
- Enhanced T-cell suppressor activity observed in some untreated patients.
Conclusions:
- Hyperprolactinemia induces specific T-cell alterations.
- Dopamine agonist therapy can reverse these immunological changes.
- Confirms a significant link between neuroendocrine and immune systems in humans.